The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

[HTML][HTML] Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden

M Lyon, JL Fullerton, S Kennedy, LM Work - Pharmacology & Therapeutics, 2024 - Elsevier
Dementia is a common cause of disability and dependency among the elderly due to its
progressive neurodegenerative nature. As there is currently no curative therapy, it is of major …

Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images

B Zhao, T Li, Z Fan, Y Yang, J Shu, X Yang, X Wang… - Science, 2023 - science.org
Cardiovascular health interacts with cognitive and mental health in complex ways, yet little is
known about the phenotypic and genetic links of heart-brain systems. We quantified heart …

A randomized, double-blinded, placebo-controlled study to compare the safety and efficacy of low dose enhanced wild blueberry powder and wild blueberry extract …

AR Whyte, N Cheng, E Fromentin, CM Williams - Nutrients, 2018 - mdpi.com
Previous research has shown beneficial effects of polyphenol-rich diets in ameliorating
cognitive decline in aging adults. Here, using a randomized, double blinded, placebo …

Efficacy and safety of Chinese herbal medicine compared with losartan for mild essential hypertension: A randomized, multicenter, double-blind, noninferiority trial

X Lai, Z Dong, S Wu, X Zhou, G Zhang… - … Quality and Outcomes, 2022 - Am Heart Assoc
Background: Hypertension is one of the most challenging public health problems worldwide.
Previous studies suggested that the Songling Xuemaikang capsule (SXC)—a Chinese …

Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how—a decision-making support from the …

A Scuteri, A Benetos, C Sierra, A Coca… - Journal of …, 2021 - journals.lww.com
The guidelines on hypertension recently published by the European Societies of
Hypertension and Cardiology, have acknowledged cognitive function (and its decline) as a …

Neuropsychiatric consequences of lipophilic beta-blockers

SA Cojocariu, A Maștaleru, RA Sascău, C Stătescu… - Medicina, 2021 - mdpi.com
Beta-blockers are a class of drugs with important benefits in cardiovascular pathology. In this
paper, we aim to highlight their adverse and therapeutic effects in the neuropsychiatric field …

Angiotensin receptor blockers and cognition: a scoping review

Z Zhou, SG Orchard, MR Nelson, MA Fravel… - Current hypertension …, 2024 - Springer
Abstract Purpose of Review To provide an overview of the association between angiotensin
II receptor blocker (ARB) use and cognitive outcomes. Recent Findings ARBs have …

Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD) 5: Guidelines for management of vascular cognitive impairment

EE Smith, P Barber, TS Field, A Ganesh… - … Research & Clinical …, 2020 - Wiley Online Library
Introduction Vascular disease is a common cause of dementia, and often coexists with other
brain pathologies such as Alzheimer's disease to cause mixed dementia. Many of the risk …

Differences in cognitive performance and cognitive decline across European regions: a population-based prospective cohort study

T Formanek, A Kagstrom, P Winkler… - European …, 2019 - cambridge.org
Background: A large variation in cognitive performance exists between European regions.
However, it is unclear how older Europeans differ in the rate of cognitive decline. Methods …